Clevidipine butyrate: a promising new drug for the management of acute hypertension

Bibliography

• Cutler J, Sorlie P, Wolz M, Trends in hypertension prevalence, awareness, treatment and control rates in United States adults between 1988 – 1994 and 1999 – 2004. Hypertension 2008;52:818-27
   PubMed Web of Science ®Google Scholar
• Peacock WF, Angeles JE, Soto KM, Parenteral clevidipine for the acute control of blood pressure in the critically ill patient: a review. Ther Clin Risk Manag 2009;5:627-34
   PubMedGoogle Scholar
• Chobania AV, Bakris GL, Black HR, Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52
   PubMedGoogle Scholar
• Hajjar I, Kotchen TA. Trends and prevalence, awareness, treatment, and control of hypertension in the United States, 1998 – 2000. JAMA 2003;290:199-206
   PubMed Web of Science ®Google Scholar
• Greenland P, Knoll MD, Stamler J, Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003;290:891-7
   PubMed Web of Science ®Google Scholar
• Cherry DK, Hing E, Woodwell DA, National ambulatory medical care survey: 2006 summary. Natl Health Stat Rep 2008;3:1-39
   PubMedGoogle Scholar
• Wilson PW. Established risk factors and coronary artery disease: the Framingham study. Am J Hypertens 1994;7:7-12
   PubMed Web of Science ®Google Scholar
• Levy D, Larson MG, Vasan RS, The progression from hypertension to congestive heart failure. JAMA 1996;275:1557-62
   PubMed Web of Science ®Google Scholar
• Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 2000;102:470-9
   PubMed Web of Science ®Google Scholar
• Staessen JA, Fagard R, Thijs L, Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe Trial Investigators. Lancet 1997;350:757-64
   PubMed Web of Science ®Google Scholar
• Thrift AG, McNeill JJ, Forbes A, Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group. Stroke 1996;27:2020-5
   PubMed Web of Science ®Google Scholar
• Coresh J, Wei GL, McQuillan G, Prevelance of high blood pressure and elevated serum creatinine level in the United States: findings from the Third National Health and Nutrition Examination Survey (1988 – 1994). Arch Intern Med 2001;161:1207-16
   PubMed Web of Science ®Google Scholar
• Hsu CY, McCulloch CE, Darbinian J, Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 2005;165:923-8
   PubMed Web of Science ®Google Scholar
• Kaplan NM. Management of hypertensive emergencies. Lancet 1994;344:1335-8
   PubMed Web of Science ®Google Scholar
• Ahmed ME, Walker JM, Beevers DG, Lack of difference between malignant and accelerated hypertension. Br Med J 1986;292:235-7
   PubMed Web of Science ®Google Scholar
• Phillips SJ, Whisnant JP. Hypertension and the brain. Arch Intern Med 1992;152:938-45
   PubMed Web of Science ®Google Scholar
• Strandgaard S, Paulson OB. Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens 1989;2:486-92
   PubMedGoogle Scholar
• Grossman E, Messerli FH, Grodzicki T, Should a moratorium be placed on sublingual nifedipine capsules for hypertensive emergencies or pseudoemergencies? JAMA 1996;276:1328-31
   PubMed Web of Science ®Google Scholar
• Haas DC, Streeten DHP, Kim RC, Death from cerebral hypoperfusion during nitroprusside treatment of acute angiotensin-dependent hypertension. Am J Med 1983;75:1071-6
   PubMedGoogle Scholar
• Materson BJ, Reda DJ, Cushman WC, Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-21
   PubMed Web of Science ®Google Scholar
• Eisenberg MJ, Brox A, Bestawros AN. Calcium channel blockers: an update. Am J Med 2004;116:35-43
   PubMed Web of Science ®Google Scholar
• Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Engl J Med 1999;341:1447-57
   PubMed Web of Science ®Google Scholar
• Severe symptomless hypertension. Lancet 1989;2:1369-70
   PubMedGoogle Scholar
• Handler J. Hypertensive urgency. J Clin Hypertens 2006;8:61-4
   PubMedGoogle Scholar
• Cherney D, Straus S. Management of patients with hypertensive urgencies and emergencies: a systematic review of the literature. J Gen Intern Med 2002;17:937-45
   PubMed Web of Science ®Google Scholar
• Dix P, Howell S. Survey of cancellation rate of hypertensive patients undergoing anaesthesia and elective surgery. Br J Anaesth 2001;86:789-93
   PubMed Web of Science ®Google Scholar
• Wolfsthal SD. Is blood pressure control necessary before surgery? Med Clin North Am 1993;77:349-63
   PubMedGoogle Scholar
• Goldman L, Caldera DL. Risks of general anesthesia and elective operation in the hypertensive patient. Anesthesiology 1979;50:285-92
   PubMed Web of Science ®Google Scholar
• Rhoney D, Peacock WF. Intravenous therapy for hypertensive emergencies, part 1. Am J Health Syst Pharm 2009;66:1343-52
   PubMed Web of Science ®Google Scholar
• Rhoney D, Peacock WF. Intravenous therapy for hypertensive emergencies, part 2. Am J Health Syst Pharm 2009;66:1448-57
   PubMed Web of Science ®Google Scholar
• Varon J. Treatment of acute severe hypertension: current and newer agents. Drugs 2008;68:283-97
   PubMed Web of Science ®Google Scholar
• Varon J, Marik PE. Perioperative hypertension management. Vasc Health Risk Manag 2008;4:615-27
   PubMedGoogle Scholar
• Adis International Limited. Intravenous antihypertensives important in achieving blood pressure control in the perioperative setting. Drugs Ther Perspect 2008;24:9-12
   Google Scholar
• Levy JH. Treatment of perioperative hypertension. Anesthesiol Clin North Am 1999;17:567-79
   Google Scholar
• The Medicines Company Cleviprex® (Clevidipine Butyrate) injectable emulsion for intravenous use: US prescribing information [online] Available from: http//www.cleviprex.com/media/ClevidipinePI.pdf [Last accessed 16 September 2009]
   Google Scholar
• CDER New Molecular Entity (NME) Drug and New Biologic Approvals for Calendar Year 2008 FDA Public Health Advisory. Washington, DC: FDA/Center for Drug Evaluation and Research, 2008. Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ DrugandBiologicApprovalReports/NMEDrugandNewBiologicApprovals/UCM081805.pdf [Last accessed 16 September 2009]
   Google Scholar
• Nordlander M, Sjöquist P, Ericsson H, Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. Cardiovasc Drug Rev 2004;22:227-50
   PubMed Web of Science ®Google Scholar
• Noviawaty I, Uzun G, Qureshi AI. Drug evaluation of clevidipine for acute hypertension. Expert Opin Pharmacother 2008;9:2519-29
   PubMed Web of Science ®Google Scholar
• Sorbera LA, Castanera J. Clevidipine. Drugs Future 2004;29:105-11
   Google Scholar
• Ericsson H, Fakt C, Jolin-Mellgård Å, Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers. Br J Clin Pharmacol 1999;47:531-8
   PubMed Web of Science ®Google Scholar
• Ericsson H, Fakt C, Höglund L, Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion. Eur J Clin Pharmacol 1999;55:61-7
   PubMed Web of Science ®Google Scholar
• Prlesi L, Cheng-Lai A. Clevidipine: a novel ultra-short-acting calcium antagonist. Cardiol Rev 2009;17:147-52
   PubMed Web of Science ®Google Scholar
• Ericsson H, Bredberg U, Eriksson U, Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers. Anesthesiology 2000;92:993-1001
   PubMed Web of Science ®Google Scholar
• Schwieler JH, Ericsson H, Löfdahl P, Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans. J Cardiovasc Pharmacol 1999;34:268-74
   PubMed Web of Science ®Google Scholar
• Ericsson H, Schwieler J, Lindmark B, Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients. Chirality 2001;13:130-4
   PubMed Web of Science ®Google Scholar
• Kieler-Jensen N, Jolin-Mellgård Å, Nordlander M, Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery. Acta Anaesthesiol Scand 2000;44:186-93
   PubMed Web of Science ®Google Scholar
• Bailey JM, Lu W, Levy JH, Clevidipine in adult cardiac surgical patients. Anesthesiology 2002;96:1086-94
   PubMed Web of Science ®Google Scholar
• Powroznyk AVV, Vuylsteke A, Naughton C, Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgery. Eur J Anaesthesiol 2003;20:697-703
   PubMed Web of Science ®Google Scholar
• Levy JH, Manacao MY, Gitter R, Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Anesth Analg 2007;105:918-25
   PubMed Web of Science ®Google Scholar
• Singla N, Warltier DC, Gandhi SD, Treatment of acute postoperative hypertension in cardiac surgery patients; an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized double-blind, placebo-controlled trial. Anesth Analg 2008;107:59-67
   PubMed Web of Science ®Google Scholar
• Aronson S, Cornelius CM, Stierer KA, Comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for scute hypertension treatment in cardiac surgery patients: the ECLIPSE trials. Anesth Analg 2008;107:1110-21
   PubMed Web of Science ®Google Scholar
• Pollack CV, Varon J, Garrison NA, Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med 2009;53:329-38
   PubMed Web of Science ®Google Scholar
• Graffagnino C, Bergese SD, Love J, ; on behalf of the ACCELERATE Investigators. Clevidipine rapidly and safely reduces blood pressure in patients with acute intracerebral hemorrhage: interim results of the ‘ACCELERATE’ trial. 7th Neurocritical Care Society Meeting, Hilton New Orleans Riverside, New Orleans, LA, 11 – 14 November 2009
   Google Scholar
• Zhang H. Clevidipine® The Medicines Company. Curr Opin Investig Drugs 2002;3:1474-8
   PubMedGoogle Scholar
• Kenyon KW. Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension. Ann Pharmacother 2009;43:1258-68
   PubMed Web of Science ®Google Scholar
• Deeks ED, Keating GM, Keam SJ. Clevidipine: a review of its use in the management of acute hypertension. Am J Cardiovasc Drugs 2009;9:117-34
   PubMed Web of Science ®Google Scholar
• Chatzizisis YS, Coskun AU, Jonas M, Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007;49:2379-93
   PubMed Web of Science ®Google Scholar
• Bailey RR. Labetalol in the treatment of patients with hypertension and renal function impairment. Br J Clin Pharmacol 1979;8(Suppl 2):135-40S
   PubMedGoogle Scholar
• Chien S, Li S, Shyy YJ. Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension 1998;31:162-9
   PubMed Web of Science ®Google Scholar
• Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000;356:411-17
   PubMed Web of Science ®Google Scholar
• Devereaux PJ, Goldman L, Yusuf S, Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review. CMAJ 2005;173:779-88
   PubMed Web of Science ®Google Scholar
• Oparil S, Aronson S, Deeb GM, Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises. Am J Hypertens 1999;12:653-64
   PubMedGoogle Scholar
• Vuylsteke A, Feneck RO, Jolin-Mellgård A, Perioperative blood pressure control: a prospective survey of patient management in cardiac surgery. J Cardiothorac Vasc Anesth 2000;14:269-73
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Oparil S. Treatment of hypertensive crisis. N Engl J Med 1990;323:1177-83
   PubMed Web of Science ®Google Scholar
• Cheung AT. Exploring an optimum intra/postoperative management strategy for acute hypertension in the cardiac surgery patient. J Card Surg 2006;21 (Suppl 1):S8-14
   Google Scholar
• Weitz HH. Perioperative cardiac complications. Med Clin North Am 2001;85:1151-69
   PubMedGoogle Scholar
• Aronson S, Boisvert D, Lapp W. Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery. Anesth Analg 2002;94:1079-84
   PubMed Web of Science ®Google Scholar
• Katz JN, Gore JM, Amin A, Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hypertension (STAT) registry. Am Heart J 2009;158:599-606. e1
   PubMed Web of Science ®Google Scholar
• Ericsson H, Bredberg U, Eriksson U, Pharmacokinetics and arteriovenous differences in clevidipine concentration following short- and a long-term intravenous infusion in healthy volunteers. Anesthesiology 2000;92:993-1001
   PubMed Web of Science ®Google Scholar